LON:NFX Nuformix (NFX) Share Price, News & Analysis GBX 0.16 +0.00 (+0.63%) As of 11:25 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsNews and Trends About Nuformix Stock (LON:NFX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nuformix alerts:Sign Up Key Stats Today's Range 0.16▼ 0.1750-Day Range 0.13▼ 0.2052-Week Range 0.01▼ 0.56Volume9.71 million shsAverage Volume31.59 million shsMarket Capitalization£4.18 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom. Read More Receive NFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuformix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NFX Stock News HeadlinesNuformix Appoints Tim Metcalfe as Chairman to Support Strategic GrowthAugust 25, 2026 | uk.finance.yahoo.comNuformix gains 19% in London trade on positive NXP002 study ahead of ERS CongressAugust 19, 2026 | uk.finance.yahoo.comThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.September 2 at 1:00 AM | Porter & Company (Ad)Nuformix Reports Positive Preclinical Data for Inhaled Fibrosis Candidate NXP002August 19, 2026 | uk.finance.yahoo.comNuformix Advances Inhaled Fibrosis Therapy Following Orphan Drug Milestones and New Funding Support (NFX)May 28, 2026 | uk.finance.yahoo.comNuformix updates market on enlarged share capital and voting rightsMarch 31, 2026 | tipranks.comNuformix shares jump 12.5% as FDA grants orphan drug status for rare lung disease programmeMarch 10, 2026 | uk.finance.yahoo.comNuformix PLCFebruary 26, 2026 | marketwatch.comSee More Headlines NFX Stock Analysis - Frequently Asked Questions How have NFX shares performed this year? Nuformix's stock was trading at GBX 0.25 at the start of the year. Since then, NFX shares have decreased by 36.3% and is now trading at GBX 0.16. How were Nuformix's earnings last quarter? Nuformix plc (LON:NFX) released its quarterly earnings results on Thursday, May, 28th. The company reported ($0.02) earnings per share (EPS) for the quarter. How do I buy shares of Nuformix? Shares of NFX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Nuformix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nuformix investors own include Rolls-Royce Holdings plc (RR), UK Oil & Gas (UKOG), Ampliphi Biosciences (APHB), Argo Blockchain (ARB) and Ardelyx (ARDX). Company Calendar Last Earnings5/28/2026Today9/02/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:NFX Previous SymbolLON:LVRT CIKN/A Webwww.levrett.com Phone44 1223 423 667FaxN/AEmployees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£383.40 thousand Net MarginsN/A Pretax MarginN/A Return on Equity-83.53% Return on Assets-17.20% Debt Debt-to-Equity RatioN/A Current Ratio4.32 Quick Ratio3.35 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.05 per share Price / Cash Flow3.55 Book ValueGBX 0.54 per share Price / Book0.30Miscellaneous Outstanding Shares2,609,749,000Free FloatN/AMarket Cap£4.18 million OptionableNot Optionable Beta1.52 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (LON:NFX) was last updated on 9/2/2026 by MarketBeat.com Staff. From Our PartnersThis little-known gold fund distributes cash every FridayGold pays no dividends, no interest, no yield - it just sits there. Yet investors are reportedly collecting up...Investors Alley | SponsoredGold Explorer Sits Between Barrick’s Nevada GiantsBarrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldru...Wall Street Logic | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored#1 Stock to Own as Trump Launches Historic Mission Backing "Medical AI"The federal government is throwing its full support behind a new class of AI technology, in what's being calle...Stansberry Research | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredJon Najarian's #1 Energy Trade for 2026Elon Musk just built the largest private power network in American history. Hall of Fame Trader Jon Najarian s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuformix plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuformix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NFX Stock Alerts